Ardelyx (ARDX) Cash & Current Investments (2013 - 2026)

Ardelyx (ARDX) posted Cash & Current Investments of $238.1 million for Q1 2026, down 10.06% on a QoQ basis from $264.7 million in Q4 2025, and up 11.27% year-over-year from $214.0 million in Q1 2025.

Ardelyx (ARDX) Cash & Current Investments (2013 - 2026) Analysis & Trends

Ardelyx's Cash & Current Investments history runs 14 years deep, the most recent figure standing at $238.1 million for Q1 2026.

  • Quarterly Cash & Current Investments rose 11.27% year-over-year to $238.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $238.1 million (up 11.27% YoY) and the FY2025 annual result came in at $264.7 million, up 5.83% from the prior year.
  • Cash & Current Investments was $238.1 million for Q1 2026 at Ardelyx, down from $264.7 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $264.7 million in Q4 2025 and bottomed at $81.0 million in Q2 2022.
  • A 5-year average of $177.6 million and a median of $186.0 million in 2024 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments tumbled 52.85% — and 2023, when it soared 82.16%.
  • Ardelyx's Cash & Current Investments stood at $123.9 million in 2022, then jumped by 48.74% to $184.3 million in 2023, then soared by 35.7% to $250.1 million in 2024, then increased by 5.83% to $264.7 million in 2025, then dropped by 10.06% to $238.1 million in 2026.
  • Business Quant data shows ARDX's Cash & Current Investments at $238.1 million in Q1 2026, $264.7 million in Q4 2025, and $242.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 65,719.23 Bn 65,718.94 Bn - 283.54 Mn
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - 61.40 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.85 Bn 467.06 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 122.29 Bn 115.04 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 70.04 Bn 61.28 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.06 Bn 62.06 Bn - -
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn 5.18 Bn
9 Alnylam Pharmaceuticals 37.47 Bn 34.47 Bn 959.66 Mn 3.01 Bn
10 Ardelyx 1.26 Bn 1.02 Bn 89.66 Mn 238.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 238.07 Mn
Dec 31, 2025 264.69 Mn
Sep 30, 2025 242.71 Mn
Jun 30, 2025 238.45 Mn
Mar 31, 2025 213.95 Mn
Dec 31, 2024 250.10 Mn
Sep 30, 2024 190.40 Mn
Jun 30, 2024 185.96 Mn
Mar 31, 2024 202.58 Mn
Dec 31, 2023 184.30 Mn
Sep 30, 2023 165.08 Mn
Jun 30, 2023 127.58 Mn
Mar 31, 2023 130.37 Mn
Dec 31, 2022 123.91 Mn
Sep 30, 2022 90.62 Mn
Jun 30, 2022 81.01 Mn
Mar 31, 2022 89.70 Mn
Dec 31, 2021 116.69 Mn
Sep 30, 2021 141.65 Mn
Jun 30, 2021 171.81 Mn